STING1 and neoplasm: The in vitro and in vivo studies demonstrate that the MHN NGs can activate the cascade tumor pyroptosis and cGAS‐STING immunotherapy under the US treatment through the synergistic effects of generated NO and released Mn2+, resulting in the effective inhibition of tumor growth.